Clinical trial

Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma

NCT05854030

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-04-01

PhaseN/A

Study timeline

Study start (actual)2022-04-01Date precision: day

Registry last updated2023-05-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Neoplasmunresolved

Squamous Cell Carcinomaunresolved

Exosomesunresolved

Interventions

collect plasma samples and clinical featuresDIAGNOSTIC_TEST

Sponsors & collaborators

Tianjin Medical University Cancer Institute and Hospitallead sponsor

Tianjin Chest Hospitalcollaborator

Mapped research locations

TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05854030 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.